Literature DB >> 21703526

The impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction.

Dmitry Abramov1, Kun-Lun He, Jie Wang, Daniel Burkhoff, Mathew S Maurer.   

Abstract

BACKGROUND: Extracardiac comorbidities are common in patients with heart failure and a preserved ejection fraction (HFPEF). We sought to evaluate the relationship between comorbidities and ventricular structure and function in patients with HFPEF through evaluation of pressure-volume analysis. METHODS AND
RESULTS: Two hundred twenty Chinese patients with a preserved ejection fraction who were either healthy (n = 75), hypertensive without heart failure (HTN; n = 89), or hypertensive with HFPEF (HFPEF; n = 56) were studied. Using echocardiographic measures, estimated end-systolic and end-diastolic pressure-volume relationships, and the area between them as a function of EDP, the isovolumic pressure-volume areas (PVA(iso)), were calculated. Ventricular capacitance, as measured by V(30), was larger in patients with HFPEF compared with normal control subjects and tended to be larger compared with hypertensive control subjects. The presence of diabetes and renal insufficiency was independently associated with greater ventricular capacitance in patients with HFPEF. The PVA(iso) was increased in patients with HFPEF compared with HTN and normal control subjects, and in particular, it was increased in HFPEF patients with multiple comorbidities.
CONCLUSIONS: The presence of comorbid conditions is associated with altered pressure-volume relations and enhanced pump function in subjects with HFPEF, supporting an important role for extracardiac comorbidities in the pathophysiology of patients with this condition.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21703526      PMCID: PMC3124657          DOI: 10.1016/j.cardfail.2011.03.010

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  48 in total

1.  Trends in prevalence and outcome of heart failure with preserved ejection fraction.

Authors:  Theophilus E Owan; David O Hodge; Regina M Herges; Steven J Jacobsen; Veronique L Roger; Margaret M Redfield
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

2.  The perindopril in elderly people with chronic heart failure (PEP-CHF) study.

Authors:  John G F Cleland; Michal Tendera; Jerzy Adamus; Nick Freemantle; Lech Polonski; Jacqueline Taylor
Journal:  Eur Heart J       Date:  2006-09-08       Impact factor: 29.983

3.  Outcome of heart failure with preserved ejection fraction in a population-based study.

Authors:  R Sacha Bhatia; Jack V Tu; Douglas S Lee; Peter C Austin; Jiming Fang; Annick Haouzi; Yanyan Gong; Peter P Liu
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

4.  Type II diabetic mice exhibit contractile dysfunction but maintain cardiac output by favourable loading conditions.

Authors:  An Van den Bergh; Willem Flameng; Paul Herijgers
Journal:  Eur J Heart Fail       Date:  2006-05-22       Impact factor: 15.534

5.  Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study.

Authors:  Mathew S Maurer; Daniel Burkhoff; Linda P Fried; John Gottdiener; Donald L King; Dalane W Kitzman
Journal:  J Am Coll Cardiol       Date:  2007-02-20       Impact factor: 24.094

6.  Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well.

Authors:  B Daan Westenbrink; Folkert W Visser; Adriaan A Voors; Tom D J Smilde; Erik Lipsic; Gerjan Navis; Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen
Journal:  Eur Heart J       Date:  2006-12-11       Impact factor: 29.983

Review 7.  Ventricular pump function in heart failure with normal ejection fraction: insights from pressure-volume measurements.

Authors:  Mathew S Maurer; Itzhak Kronzon; Daniel Burkhoff
Journal:  Prog Cardiovasc Dis       Date:  2006 Nov-Dec       Impact factor: 8.194

Review 8.  Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists.

Authors:  Donald S Silverberg; Dov Wexler; Adrian Iaina; Shoshana Steinbruch; Y Wollman; Doron Schwartz
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

9.  Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study.

Authors:  Christophe Tribouilloy; Dan Rusinaru; Haïfa Mahjoub; Vicky Soulière; Franck Lévy; Marcel Peltier; Michel Slama; Ziad Massy
Journal:  Eur Heart J       Date:  2007-12-22       Impact factor: 29.983

10.  Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.

Authors:  Gregg C Fonarow; Wendy Gattis Stough; William T Abraham; Nancy M Albert; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Journal:  J Am Coll Cardiol       Date:  2007-08-06       Impact factor: 24.094

View more
  10 in total

Review 1.  A multidimensional sight on cardiac failure: uncovered from structural to molecular level.

Authors:  Vijay Urmaliya; Gustavo Franchelli
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

2.  Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction.

Authors:  Scott L Hummel; E Mitchell Seymour; Robert D Brook; Theodore J Kolias; Samar S Sheth; Hannah R Rosenblum; Joanna M Wells; Alan B Weder
Journal:  Hypertension       Date:  2012-10-01       Impact factor: 10.190

3.  Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy.

Authors:  Mathew S Maurer; Sergio Teruya; Bibhas Chakraborty; Stephen Helmke; Donna Mancini
Journal:  Circ Heart Fail       Date:  2012-12-20       Impact factor: 8.790

Review 4.  New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.

Authors:  Michele Senni; Walter J Paulus; Antonello Gavazzi; Alan G Fraser; Javier Díez; Scott D Solomon; Otto A Smiseth; Marco Guazzi; Carolyn S P Lam; Aldo P Maggioni; Carsten Tschöpe; Marco Metra; Scott L Hummel; Frank Edelmann; Giuseppe Ambrosio; Andrew J Stewart Coats; Gerasimos S Filippatos; Mihai Gheorghiade; Stefan D Anker; Daniel Levy; Marc A Pfeffer; Wendy Gattis Stough; Burkert M Pieske
Journal:  Eur Heart J       Date:  2014-08-07       Impact factor: 29.983

5.  Abnormal left ventricular relaxation and symptoms of heart failure.

Authors:  Maryam Nabati; Safora Salehi; Babak Bagheri; Mahmoud Nouraei
Journal:  J Echocardiogr       Date:  2016-04-04

6.  Impact of epoetin alfa on left ventricular structure, function, and pressure volume relations as assessed by cardiac magnetic resonance: the heart failure preserved ejection fraction (HFPEF) anemia trial.

Authors:  Philip Green; Benson A Babu; Sergio Teruya; Stephen Helmke; Martin Prince; Mathew S Maurer
Journal:  Congest Heart Fail       Date:  2013-03-20

Review 7.  Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life?

Authors:  Jia Li; Peter Moritz Becher; Stefan Blankenberg; Dirk Westermann
Journal:  Cardiol Res Pract       Date:  2013-10-24       Impact factor: 1.866

8.  Age, Gender and Load-Related Influences on Left Ventricular Geometric Remodeling, Systolic Mid-Wall Function, and NT-ProBNP in Asymptomatic Asian Population.

Authors:  Chi Chen; Kuo-Tzu Sung; Shou-Chuan Shih; Chuan-Chuan Liu; Jen-Yuan Kuo; Charles Jia-Yin Hou; Chung-Lieh Hung; Hung-I Yeh
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

9.  Mimicking the cardiac cycle in intact cardiomyocytes using diastolic and systolic force clamps; measuring power output.

Authors:  Michiel Helmes; Aref Najafi; Bradley M Palmer; Ernst Breel; Niek Rijnveld; Davide Iannuzzi; Jolanda van der Velden
Journal:  Cardiovasc Res       Date:  2016-04-01       Impact factor: 10.787

10.  Passive Stiffness of Left Ventricular Myocardial Tissue Is Reduced by Ovariectomy in a Post-menopause Mouse Model.

Authors:  Núria Farré; Ignasi Jorba; Marta Torres; Bryan Falcones; Julio Martí-Almor; Ramon Farré; Isaac Almendros; Daniel Navajas
Journal:  Front Physiol       Date:  2018-11-05       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.